Regulatory & compounding

Approved products, compounding, and quality control

Semaglutide is FDA-approved only as specific prescription products for specific indications; it is not an over-the-counter peptide. During shortages, compounded versions proliferated, and the FDA has flagged real quality and dosing concerns with them.

This unit walks the approved-versus-compounded distinction and checks a common claim: that compounded salt forms are equivalent to the approved product. Framing everything as clinician-supervised prescription use is the responsible stance.